119 related articles for article (PubMed ID: 19023543)
21. PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome.
Van de Ven H; Paulussen C; Feijens PB; Matheeussen A; Rombaut P; Kayaert P; Van den Mooter G; Weyenberg W; Cos P; Maes L; Ludwig A
J Control Release; 2012 Aug; 161(3):795-803. PubMed ID: 22641062
[TBL] [Abstract][Full Text] [Related]
22. Biochemical characterization of GM1 micelles-Amphotericin B interaction.
Leonhard V; Alasino RV; Bianco ID; Garro AG; Heredia V; Beltramo DM
Curr Drug Deliv; 2015; 12(4):406-14. PubMed ID: 25772153
[TBL] [Abstract][Full Text] [Related]
23. In vitro cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines.
Leon CG; Lee J; Bartlett K; Gershkovich P; Wasan EK; Zhao J; Clement JG; Wasan KM
Lipids Health Dis; 2011 Aug; 10():144. PubMed ID: 21854638
[TBL] [Abstract][Full Text] [Related]
24. Poly(L-lactide) Nanoparticles Reduce Amphotericin B Cytotoxicity and Maintain Its In Vitro Antifungal Activity.
Casa DM; Carraro TC; de Camargo LE; Dalmolin LF; Khalil NM; Mainardes RM
J Nanosci Nanotechnol; 2015 Jan; 15(1):848-54. PubMed ID: 26328449
[TBL] [Abstract][Full Text] [Related]
25. Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis.
Souza RO; Henrique de Lima T; Oréfice RL; de Freitas Araújo MG; de Lima Moura SA; Magalhães JT; da Silva GR
J Pharm Sci; 2018 Oct; 107(10):2674-2685. PubMed ID: 29940181
[TBL] [Abstract][Full Text] [Related]
26. Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method.
Kim JC; Lee EO; Kim JY; Bae SK; Choi TB; Kim JD
Pharm Dev Technol; 1997 Aug; 2(3):275-84. PubMed ID: 9552455
[TBL] [Abstract][Full Text] [Related]
27. Development of polyion complex micelles for encapsulating and delivering amphotericin B.
Wang CH; Wang WT; Hsiue GH
Biomaterials; 2009 Jul; 30(19):3352-8. PubMed ID: 19299011
[TBL] [Abstract][Full Text] [Related]
28. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
29. Drug Delivery of Amphotericin B through Core-Shell Composite Based on PLGA/Ag/Fe
Sadat Akhavi S; Moradi Dehaghi S
Appl Biochem Biotechnol; 2020 Jun; 191(2):496-510. PubMed ID: 31797150
[TBL] [Abstract][Full Text] [Related]
30. Self-assembling cashew gum-graft-polylactide copolymer nanoparticles as a potential amphotericin B delivery matrix.
Richter AR; Carneiro MJ; de Sousa NA; Pinto VPT; Freire RS; de Sousa JS; Mendes JFS; Fontenelle ROS; Feitosa JPA; Paula HCB; Goycoolea FM; de Paula RCM
Int J Biol Macromol; 2020 Jun; 152():492-502. PubMed ID: 32097738
[TBL] [Abstract][Full Text] [Related]
31. The synergistic fungicidal effect of low-frequency and low-intensity ultrasound with amphotericin B-loaded nanoparticles on C. albicans in vitro.
Yang M; Xie S; Adhikari VP; Dong Y; Du Y; Li D
Int J Pharm; 2018 May; 542(1-2):232-241. PubMed ID: 29559330
[TBL] [Abstract][Full Text] [Related]
32. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
[TBL] [Abstract][Full Text] [Related]
33. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
34. Spectroscopic investigation of the aggregation state of amphotericin B during loading, freeze-drying, and reconstitution of polymeric micelles.
Adams M; Kwon GS
J Pharm Pharm Sci; 2004 Nov; 7(4):1-6. PubMed ID: 15850542
[TBL] [Abstract][Full Text] [Related]
35. Effect of Star Topology Versus Linear Polymers on Antifungal Activity and Mammalian Cell Toxicity.
Schaefer S; Melodia D; Corrigan N; Lenardon MD; Boyer C
Macromol Biosci; 2024 May; 24(5):e2300452. PubMed ID: 38009827
[TBL] [Abstract][Full Text] [Related]
36. Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles.
Souza AC; Nascimento AL; de Vasconcelos NM; Jerônimo MS; Siqueira IM; R-Santos L; Cintra DO; Fuscaldi LL; Pires Júnior OR; Titze-de-Almeida R; Borin MF; Báo SN; Martins OP; Cardoso VN; Fernandes SO; Mortari MR; Tedesco AC; Amaral AC; Felipe MS; Bocca AL
Eur J Med Chem; 2015 May; 95():267-76. PubMed ID: 25827397
[TBL] [Abstract][Full Text] [Related]
37. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
38. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
40. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length.
Adams ML; Kwon GS
J Control Release; 2003 Feb; 87(1-3):23-32. PubMed ID: 12618020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]